Correlation Between Affimed NV and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Affimed NV and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affimed NV and Passage Bio, you can compare the effects of market volatilities on Affimed NV and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and Passage Bio.
Diversification Opportunities for Affimed NV and Passage Bio
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Affimed and Passage is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Affimed NV i.e., Affimed NV and Passage Bio go up and down completely randomly.
Pair Corralation between Affimed NV and Passage Bio
Given the investment horizon of 90 days Affimed NV is expected to under-perform the Passage Bio. But the stock apears to be less risky and, when comparing its historical volatility, Affimed NV is 2.21 times less risky than Passage Bio. The stock trades about -0.2 of its potential returns per unit of risk. The Passage Bio is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 67.00 in Passage Bio on December 29, 2024 and sell it today you would lose (29.00) from holding Passage Bio or give up 43.28% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Affimed NV vs. Passage Bio
Performance |
Timeline |
Affimed NV |
Passage Bio |
Affimed NV and Passage Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Affimed NV and Passage Bio
The main advantage of trading using opposite Affimed NV and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.Affimed NV vs. ADC Therapeutics SA | Affimed NV vs. Agenus Inc | Affimed NV vs. X4 Pharmaceuticals | Affimed NV vs. Terns Pharmaceuticals |
Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |